Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

31.39 +0.67 (+2.18%)
Official Closing Price Updated: 7:00 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 89,857,666
Open 31.01
Bid (Size) 31.28 (42)
Ask (Size) 31.29 (3)
Prev. Close 30.72
Today's Range 29.78 - 31.54
52wk Range 25.20 - 37.19
Shares Outstanding 5,606,688,356
Dividend Yield 5.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact from the 2026 Medicare drug price cuts, easing initial industry concerns. 
Via Benzinga

Performance

YTD
+5.58%
+5.58%
1 Month
+11.23%
+11.23%
3 Month
+22.52%
+22.52%
6 Month
+16.17%
+16.17%
1 Year
-12.95%
-12.95%

More News

Read More
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Pfizer $PFE Beats Earnings Estimates
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Of The Day: Pfizer Pattern Offers Lessons After Better-Than-Expected Q2 Results
Via Benzinga
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
Via Benzinga
Exposures COVID-19
PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Dow Jumps 200 Points; Pfizer Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
(PFE) - Analyzing Pfizer's Short Interest
Via Benzinga
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Via Benzinga
Topics Economy
Exposures Interest Rates
Pfizer Marks First Revenue Growth Since COVID Revenue Peak In 2022, Lifts Annual Guidance
Via Benzinga
Exposures COVID-19
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Via Benzinga
Pfizer Inc. Beats Q2 Market Expectations With $13.3 Billion In Revenue
Via Talk Markets
Pfizer Stock Rises On Earnings Beat, Raised Outlook
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance
From Pfizer Inc.
Via Business Wire
Nasdaq, S&P Futures Rise As Microsoft, AMD Earnings Take Spotlight: Will Fed Provide 'Turbo Boost' For Market? Analyst Weighs In
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
10 Best Ultra-High-Yield Dividend Stocks to Consider as Part of a Long-Term Portfolio
Via The Motley Fool
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
US Stocks Close Mixed Ahead Of Big Earnings, Fed Decision: Investor Optimism Improves Further
Via Benzinga
Topics Economy
Exposures Interest Rates
Procter & Gamble, Microsoft And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Via Benzinga
Prediction: This Will Be Pfizer's Next Big Move
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.